0001367644-21-000101.txt : 20210527 0001367644-21-000101.hdr.sgml : 20210527 20210527163750 ACCESSION NUMBER: 0001367644-21-000101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210525 FILED AS OF DATE: 20210527 DATE AS OF CHANGE: 20210527 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zoon Kathryn C CENTRAL INDEX KEY: 0001685720 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 21973298 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DRIVE STREET 2: SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wf-form4_162214773924582.xml FORM 4 X0306 4 2021-05-25 0 0001367644 Emergent BioSolutions Inc. EBS 0001685720 Zoon Kathryn C 400 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2021-05-25 4 S 0 3139 56.48 D 14377 D Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.11 to $56.86. /s/ S. Scott Lieberman, Attorney-in-fact 2021-05-27